Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies
1998

Role of Nitric Oxide in Pancreatic Tumor Growth

Sample size: 24 publication Evidence: moderate

Author Information

Author(s): A Hajri, E Metzger, F Vallat, S Coffy, E Flatter, S Evrard, J Marescaux, M Aprahamian

Primary Institution: Institut de Recherche contre les Cancers de I'Appareil Digestif (IRCAD)

Hypothesis

The study aims to examine the growth effects of nitric oxide (NO) on pancreatic tumors.

Conclusion

The study found that both exogenous and endogenous nitric oxide can inhibit pancreatic tumor growth.

Supporting Evidence

  • Both sodium nitroprusside and L-arginine significantly reduced tumor growth in vivo.
  • High levels of nitric oxide were associated with increased apoptosis in tumor cells.
  • Macrophages activated by tumor cells produced more nitric oxide, enhancing tumor growth inhibition.

Takeaway

Nitric oxide can help slow down the growth of pancreatic tumors, like a superhero fighting bad guys.

Methodology

The study used in vivo experiments on rats and in vitro experiments on human pancreatic tumor cell lines to assess the effects of nitric oxide.

Limitations

The study did not test the effects of NO scavengers and specific iNOS inhibitors.

Participant Demographics

Male Lewis rats and male C3H/HeN mice were used in the study.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication